✨
AI Summary
- Airway Therapeutics CEO discusses zelpultide alfa for preventing BPD in preterm infants.
- Phase Ib study shows reduced BPD incidence and ventilation time.
- Challenges of neonatal trials and regulatory pathways for vulnerable populations.